Stock Analysis on Net
Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

This company has been moved to the archive! The financial data has not been updated since February 15, 2024.

Debt to Equity
since 2005

Microsoft Excel

Calculation

Vertex Pharmaceuticals Inc., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Total long-term obligations1 ÷ Shareholders’ equity1
Dec 31, 2023 0.02 = 426,700 ÷ 17,580,400
Dec 31, 2022 0.03 = 471,600 ÷ 13,912,700
Dec 31, 2021 0.06 = 556,700 ÷ 10,100,000
Dec 31, 2020 0.07 = 581,476 ÷ 8,686,815
Dec 31, 2019 0.09 = 568,869 ÷ 6,085,244
Dec 31, 2018 0.13 = 586,821 ÷ 4,435,203
Dec 31, 2017 0.29 = 583,902 ÷ 2,028,579
Dec 31, 2016 0.71 = 821,335 ÷ 1,156,582
Dec 31, 2015 0.86 = 810,981 ÷ 939,967
Dec 31, 2014 0.75 = 807,141 ÷ 1,075,006
Dec 31, 2013 0.36 = 489,691 ÷ 1,356,405
Dec 31, 2012 0.68 = 683,201 ÷ 999,180
Dec 31, 2011 0.58 = 455,950 ÷ 786,843
Dec 31, 2010 1.07 = 536,991 ÷ 503,973
Dec 31, 2009 0.14 = 153,836 ÷ 1,096,346
Dec 31, 2008 1.20 = 287,500 ÷ 238,874
Dec 31, 2007 0.07 = 19,997 ÷ 271,295
Dec 31, 2006 0.24 = 121,747 ÷ 505,935
Dec 31, 2005 0.75 = 180,097 ÷ 239,176

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

Comparison to Competitors

Vertex Pharmaceuticals Inc., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Vertex Pharmaceuticals Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2023 0.02 5.73 10.37 1.35 0.34 2.34 1.09 0.43 0.93 0.04 0.81 0.10 0.75
Dec 31, 2022 0.03 3.67 10.64 1.27 0.39 1.52 1.19 0.52 0.67 0.06 0.37 0.12 0.78
Dec 31, 2021 0.06 4.98 4.97 1.24 0.49 1.88 1.27 0.46 0.87 0.05 0.50 0.14 0.85
Dec 31, 2020 0.07 6.58 3.51 1.34 0.53 2.94 1.73 0.56 1.26 0.05 0.63 0.24 0.63
Dec 31, 2019 0.09 — 3.09 0.91 0.72 5.88 1.09 0.47 1.02 0.03 0.83 0.06 0.60
Dec 31, 2018 0.13 — 2.71 0.52 0.35 1.30 1.28 0.51 0.94 0.03 0.66 0.08 0.69
Dec 31, 2017 0.29 7.33 1.40 0.68 0.40 1.18 1.64 0.57 0.71 — 0.60 0.11 0.83
Dec 31, 2016 0.71 7.95 1.16 0.41 0.53 0.74 1.39 0.39 0.62 — 0.71 0.11 0.77
Dec 31, 2015 0.86 8.03 1.12 0.47 0.54 0.55 1.20 0.28 0.59 — 0.60 0.10 0.59
Dec 31, 2014 0.75 8.62 1.19 0.53 0.15 0.52 0.80 0.27 0.44 — 0.51 0.18 0.71
Dec 31, 2013 0.36 3.28 1.45 0.55 0.16 0.30 0.58 0.25 0.50 — 0.48 0.26 0.62
Dec 31, 2012 0.68 4.66 1.39 0.54 0.28 0.37 0.88 0.25 0.39 — 0.46 0.37 0.46
Dec 31, 2011 0.58 — 1.13 0.34 0.31 0.52 1.13 0.34 0.32 — 0.47 0.90 0.47
Dec 31, 2010 1.07 — 0.56 0.35 0.21 0.56 0.59 0.30 0.33 — 0.50 0.31 0.14
Dec 31, 2009 0.14 — 0.47 0.43 0.25 0.70 0.18 0.29 0.30 — 0.54 0.27 0.14
Dec 31, 2008 1.20 — 0.50 0.55 0.27 1.55 0.31 0.28 0.33 — 0.30 0.00 0.14
Dec 31, 2007 0.07 — 0.63 0.59 0.41 0.37 0.38 0.22 0.32 — 0.20 0.43 0.15
Dec 31, 2006 0.24 — 0.48 0.74 0.37 0.34 0.77 0.17 0.39 — 0.11 0.92 0.19
Dec 31, 2005 0.75 — 0.19 0.77 0.21 0.60 0.10 0.07 0.45 — 0.27 1.75 0.21

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Vertex Pharmaceuticals Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Vertex Pharmaceuticals Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2023 0.02 0.98
Dec 31, 2022 0.03 0.79
Dec 31, 2021 0.06 0.92
Dec 31, 2020 0.07 1.14
Dec 31, 2019 0.09 1.10
Dec 31, 2018 0.13 0.94
Dec 31, 2017 0.29 0.88
Dec 31, 2016 0.71 0.79
Dec 31, 2015 0.86 0.68
Dec 31, 2014 0.75 0.55
Dec 31, 2013 0.36 0.52
Dec 31, 2012 0.68 0.51
Dec 31, 2011 0.58 0.46
Dec 31, 2010 1.07 0.39
Dec 31, 2009 0.14 0.39
Dec 31, 2008 1.20 0.37
Dec 31, 2007 0.07 0.30
Dec 31, 2006 0.24 0.25
Dec 31, 2005 0.75 0.29

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Vertex Pharmaceuticals Inc., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Vertex Pharmaceuticals Inc. Health Care
Dec 31, 2023 0.02 0.81
Dec 31, 2022 0.03 0.72
Dec 31, 2021 0.06 0.78
Dec 31, 2020 0.07 0.90
Dec 31, 2019 0.09 0.91
Dec 31, 2018 0.13 0.87
Dec 31, 2017 0.29 0.79
Dec 31, 2016 0.71 0.75
Dec 31, 2015 0.86 0.68
Dec 31, 2014 0.75 0.52
Dec 31, 2013 0.36 0.49
Dec 31, 2012 0.68 0.51
Dec 31, 2011 0.58 0.45
Dec 31, 2010 1.07 0.41
Dec 31, 2009 0.14 0.41
Dec 31, 2008 1.20 0.41
Dec 31, 2007 0.07 0.36
Dec 31, 2006 0.24 0.33
Dec 31, 2005 0.75 0.30

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).